InsidersTradesSigma
Follow the Elicera Therapeutics AB share price and the full directors' dealings record of the company, a publicly traded company based in Finland. Shares trade on the FI market, under the authority of FIN-FSA. Operating in the Health Care sector, Elicera Therapeutics AB has recorded 3 public disclosures. Market capitalisation: €172.2m. The latest transaction was disclosed on 12 March 2025 (Purchase). Among the most active insiders: Margareth Jorvid. All data is openly available.
3
Insider Decl.
n/a
Thresholds
€11,763
3 ops.
Buy Volume
n/a
n/a
Sell Volume
28Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 12 March 2025
Declarations3 total
21,700 shares@ €0.16850.0024% mcap100.0% of flowInterimsaktieISIN SE0015382080FI:A003M484-1
43,211 shares@ €0.16850.0048% mcap100.0% of flowInterimsaktieISIN SE0015382080FI:A003M442-1
18,000 shares@ €0.04570.0005% mcap100.0% of flowOptionISIN SE0021626314FI:A003M381-1
3 of 3 declarations
关于 Elicera Therapeutics AB
Elicera Therapeutics AB 是一家生物制药公司，专注于开发基于先进技术的创新疗法。该公司专门从事癌症和其他严重疾病的治疗。